-
What Is The Proper Relationship Between Doctors, Patients, And Drug Companies
Consider These Five Different Points Of View Presented By The British Medical Journal In Its February 3, 2009 Edition (Posted by Tom Lamb at DrugInjuryWatch.com) On February 4, 2009, the Royal College of Physicians of London (RCP)…
-
January 2009: ETHEX Corp. Issues Voluntary Recall Of All Pills Due To Suspected Manufacturing Problems
ETHEX Recall Goes To Retail Pharmacy Level For Hydromorphone HCl Tablets And Metoprolol Succinate ER Tablets, Only; All Other ETHEX Generics Recalled To Wholesale Level (Posted by Tom Lamb at DrugInjuryWatch.com) In late December…
-
FDA Reports About Eli Lilly’s Drug Strattera Being Associated With Serious Liver Injury Cases
While Strattera Label Has Warning About Liver Injury, Does Current Version Serve To Protect The Millions Of Children Who Take This ADHD Drug? (Posted by Tom Lamb at DrugInjuryWatch.com) In the most recent FDA Drug Safety Newsletter (Volume…
-
Actavis And FDA Criticized Over Their Digitek Recall Conduct In New 2009 Report
ISMP QuarterWatch: Cannot "rule out, or state definitively, whether defective digoxin tablets led to hundreds of patient deaths" (Posted by Tom Lamb at DrugInjuryWatch.com) On January 15, 2009 The Institute for Safe Medication Practices…
-
Celgene Letter About Revlimid And Serious Skin Reactions In January 2009 Medical Journal
Discusses 16 Cases Of Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Erythema Multiforme (EM) Reported Over Two-and-a-half Years (Posted by Tom Lamb at DrugInjuryWatch.com) In an October 1, 2008 article, "FDA Alerts Doctors…